Literature DB >> 14668819

Derivation of embryonic germ cells and male gametes from embryonic stem cells.

Niels Geijsen1, Melissa Horoschak, Kitai Kim, Joost Gribnau, Kevin Eggan, George Q Daley.   

Abstract

Egg and sperm cells (gametes) of the mouse are derived from a founder population of primordial germ cells that are set aside early in embryogenesis. Primordial germ cells arise from the proximal epiblast, a region of the early mouse embryo that also contributes to the first blood lineages of the embryonic yolk sac. Embryonic stem cells differentiate in vitro into cystic structures called embryoid bodies consisting of tissue lineages typical of the early mouse embryo. Because embryoid bodies sustain blood development, we reasoned that they might also support primordial germ cell formation. Here we isolate primordial germ cells from embryoid bodies, and derive continuously growing lines of embryonic germ cells. Embryonic germ cells show erasure of the methylation markers (imprints) of the Igf2r and H19 genes, a property characteristic of the germ lineage. We show that embryoid bodies support maturation of the primordial germ cells into haploid male gametes, which when injected into oocytes restore the somatic diploid chromosome complement and develop into blastocysts. Our ability to derive germ cells from embryonic stem cells provides an accessible in vitro model system for studies of germline epigenetic modification and mammalian gametogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668819     DOI: 10.1038/nature02247

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  200 in total

1.  Divergent RNA-binding proteins, DAZL and VASA, induce meiotic progression in human germ cells derived in vitro.

Authors:  Jose V Medrano; Cyril Ramathal; Ha N Nguyen; Carlos Simon; Renee A Reijo Pera
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

2.  Establishment of a normal medakafish spermatogonial cell line capable of sperm production in vitro.

Authors:  Yunhan Hong; Tongming Liu; Haobin Zhao; Hongyan Xu; Weijia Wang; Rong Liu; Tiansheng Chen; Jiaorong Deng; Jianfang Gui
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

3.  Germ-line immortality.

Authors:  Martin M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

Review 4.  Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.

Authors:  Claudia Gundacker; Helmut Dolznig; Mario Mikula; Margit Rosner; Oliver Brandau; Markus Hengstschläger
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

5.  Gametogenesis in a dish.

Authors:  Ying Gu; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-05-29       Impact factor: 25.617

Review 6.  The next (re)generation of ovarian biology and fertility in women: is current science tomorrow's practice?

Authors:  Dori C Woods; Jonathan L Tilly
Journal:  Fertil Steril       Date:  2012-06-06       Impact factor: 7.329

7.  Derivation of male germ cells from induced pluripotent stem (iPS) cells: a novel and crucial source for generating male gametes.

Authors:  Zuping He
Journal:  Asian J Androl       Date:  2012-05-28       Impact factor: 3.285

Review 8.  Germ cell differentiation from pluripotent cells.

Authors:  Jose V Medrano; Renee A Reijo Pera; Carlos Simón
Journal:  Semin Reprod Med       Date:  2013-01-17       Impact factor: 1.303

9.  Deleted in azoospermia-like enhances in vitro derived porcine germ cell formation and meiosis.

Authors:  Bong-Wook Park; Wei Shen; Katja Linher-Melville; Julang Li
Journal:  Stem Cells Dev       Date:  2012-12-21       Impact factor: 3.272

10.  A conserved E2F6-binding element in murine meiosis-specific gene promoters.

Authors:  Sarah M Kehoe; Masahiro Oka; Katherine E Hankowski; Nina Reichert; Sandra Garcia; John R McCarrey; Stefan Gaubatz; Naohiro Terada
Journal:  Biol Reprod       Date:  2008-07-30       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.